AKBA
Akebia Therapeutics, Inc. · Healthcare
CEO and President John P. Butler sold $31K of Akebia Therapeutics, Inc.
Sold$31,416
$0.81Price
38,632Shares
−2%Stake
What AKBA did after the filing
- The stock from Wed, Mar 1 close, $0.92
- −30.4%
- S&P 500, same days
- +5.1%
Measured over 30 trading days, to the Apr 13 close.
Traded Mon, Feb 27. Filed Wed, Mar 1, 11:07 AM ET, during the session. Returns use the Mar 1 close and the Apr 13 close. Not investment advice.